Loading...
Loading...
India's lansoprazole imports from ISRAEL total $8.3M across 10 shipments from 2 foreign suppliers. TEVA PHARMACETICAL INDUSTRIES LTD. leads with $8.3M in import value; the top 5 suppliers together control 100.0% of this origin. Leading Indian buyers include ACTAVIS PHARMA DEVELOPMENT CENTRE PRIVATE LIMITED. This corridor reflects India's pharmaceutical import demand for lansoprazole — a concentrated sourcing relationship with select suppliers from ISRAEL.

TEVA PHARMACETICAL INDUSTRIES LTD. is the leading Lansoprazole supplier from ISRAEL to India, with import value of $8.3M across 8 shipments. The top 5 suppliers — TEVA PHARMACETICAL INDUSTRIES LTD., TEVA PHARMACETICAL INDUSTRIES LIMITED — collectively account for 100.0% of total import value from this origin.
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | TEVA PHARMACETICAL INDUSTRIES LTD. | $8.3M | 8 | 99.9% |
| 2 | TEVA PHARMACETICAL INDUSTRIES LIMITED | $6.2K | 2 | 0.1% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | ACTAVIS PHARMA DEVELOPMENT CENTRE PRIVATE LIMITED | $8.3M | 10 | 100.0% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Lansoprazole suppliers from ISRAEL to India include TEVA PHARMACETICAL INDUSTRIES LTD., TEVA PHARMACETICAL INDUSTRIES LIMITED. The leading supplier is TEVA PHARMACETICAL INDUSTRIES LTD. with import value of $8.3M USD across 8 shipments. India imported Lansoprazole worth $8.3M USD from ISRAEL in total across 10 shipments.
India imported Lansoprazole worth $8.3M USD from ISRAEL across 10 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Lansoprazole sourced from ISRAEL include ACTAVIS PHARMA DEVELOPMENT CENTRE PRIVATE LIMITED. The largest buyer is ACTAVIS PHARMA DEVELOPMENT CENTRE PRIVATE LIMITED with $8.3M in imports across 10 shipments.
The total value of Lansoprazole imports from ISRAEL to India is $8.3M USD, across 10 shipments and 2 foreign suppliers. Data source: Indian Customs (DGFT).
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
10 Verified Shipments
2 suppliers, 1 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists